Answers are grounded in this paper and cite their sources.
The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: